News & Perspectives
Regulatory Changes in Food and Other FDA-Regulated Consumer Products Under the Trump Administration: Minor Tweaks or Major Overhaul?
In this webinar, we will explore what any food and other FDA-regulated consumer products changes could be, what the processes would be if the government sought to implement the changes, and what companies can do to prepare.
LDT Final Rule Litigation — Status of Pending Court Challenges and What May Happen Next
With a second Trump administration coming, we summarize the current state of the two consolidated cases against the FDA and provide thoughts on where the new administration’s policy prerogatives may lead us.
FinCEN Issues Alert on the Dangers of Artificial Intelligence Deepfakes
Learn how your financial institution can identify and guard against fraud schemes associated with using deepfake media created with generative artificial intelligence tools.
Top Takeaways From the Annual Report on the SEC’s Whistleblower Program
Read our Advisory for a forecast of the future of the SEC’s whistleblower program and to learn best practices for companies regarding whistleblowing compliance.